Real-world analysis of brolucizumab in neovascular AMD

被引：0
|
作者：
Rave, Vanessa [1 ,2 ]
Sharma, Kayshaliya [1 ,2 ]
Wagner, Alan [1 ]
Kapoor, Kapil [1 ]
机构：
[1] Wagner & Kapoor Res Inst, Norfolk, VA USA
[2] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2021年 / 62卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
431
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Real-World Experience With Brolucizumab 6 mg for Diabetic Macular Edema
    Braganca, Francisca
    Ferreira, Andre
    Leite, Joao
    Coelho, Joao
    Borges, Tania
    Caiado, Filipa
    Correia, Nuno
    Beirao, Joao
    Meneres, Pedro
    Pessoa, Bernardete
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [42] Long-term efficacy and safety of brolucizumab in neovascular age-related macular degeneration: A multicentre retrospective real-world study
    Kim, Dong Ju
    Kim, Dong Geun
    Kwak, Hyun Duck
    Jang, Jae Yong
    Ji, Yong-Sok
    Lee, Seung Hyun
    Lee, Eun Kyoung
    Park, Kyu Hyung
    Kim, Jae Hui
    Lee, Jun Sung
    Song, Yumi
    Kim, Seong Taeck
    Shin, Min Ho
    Kim, Min
    Park, Sang Jun
    Joo, Kwangsic
    Sagong, Min
    Lee, Christopher Seungkyu
    Woo, Se Joon
    [J]. ACTA OPHTHALMOLOGICA, 2024,
  • [43] RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION A Systematic Review of Real-World Evidence
    Wykoff, Charles C.
    Matsumoto, Hidetaka
    Barakat, Mark R.
    Karcher, Helene
    Lozama, Anthony
    Mayhook, Andrew
    Oshagbemi, Olorunfemi A.
    Zorina, Olessia
    Hassan, Tarek S.
    Khanani, Arshad M.
    Heier, Jeffrey S.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (07): : 1051 - 1063
  • [44] Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set
    A Lotery
    R Griner
    A Ferreira
    F Milnes
    P Dugel
    [J]. Eye, 2017, 31 : 1697 - 1706
  • [45] Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set
    Lotery, A.
    Griner, R.
    Ferreira, A.
    Milnes, F.
    Dugel, P.
    [J]. EYE, 2017, 31 (12) : 1697 - 1706
  • [46] Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study - Fifty-Two- Week Outcomes
    Chakraborty, Debdulal
    Maiti, Aniruddha
    Sheth, Jay U.
    Mondal, Soumen
    Boral, Subhendu
    Nandi, Krishnendu
    Sinha, Tushar Kanti
    Das, Arnab
    [J]. CLINICAL OPHTHALMOLOGY, 2022, 16 : 4303 - 4313
  • [47] Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic
    Stepanov, Alexandr
    Studnicka, Jan
    Veith, Miroslav
    Nemec, Pavel
    Vyslouzilova, Daniela
    Koubek, Michal
    Nemcansky, Jan
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (02) : 1097 - 1104
  • [48] Real-world experience of using stereotactic radiotherapy combined with anti-vascular endothelial growth factor to treat neovascular AMD
    Creer, Rosalind
    Boonarpha, Nattapon
    Gould, Gemma
    Rajai, Azita
    Chhabra, Ramandeep
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (08) : 2411 - 2419
  • [49] Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
    Sharma, Ashish
    Kumar, Nilesh
    Parachuri, Nikulaa
    Sharma, Rohini
    Bandello, Francesco
    Kuppermann, Baruch D.
    Regillo, Carl D.
    [J]. EYE, 2020, 34 (08) : 1310 - 1312
  • [50] Comparison of a human versus deep learning-based evaluation of fluid change in real-world OCT images of neovascular AMD
    Michl, Martin
    Gerendas, Bianca S.
    Seeboeck, Philipp
    de Llano, Elisa
    Gruber, Anastasiia
    Goldbach, Felix
    Mylonas, Georgios
    Leingang, Oliver
    Buehl, Wolf
    Sacu, Stefan
    Bogunovic, Hrvoje
    Schmidt-Erfurth, Ursula
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
12345